{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:27:24Z","timestamp":1792373244107,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Developing new chemotherapeutic agents is essential for improving cancer treatment and overcoming resistance. In this study, four novel synthetic cyanochalcone derivatives were designed, synthesized, and structurally characterized using various spectroscopic techniques. Their anticancer potential was evaluated via an\u00a0MTT cytotoxicity assay against three human cancer cell lines and one normal cell line. Among the tested compounds,\n                    <jats:bold>5b<\/jats:bold>\n                    exhibited the highest cytotoxic activity against laryngeal carcinoma HEP2 cells (IC\n                    <jats:sub>50<\/jats:sub>\n                    \u2009=\u200923.93\u2009\u00b1\u20091.3 \u00b5M), whereas\n                    <jats:bold>5c<\/jats:bold>\n                    demonstrated potent cytotoxicity against breast cancer MCF-7 cells (IC\n                    <jats:sub>50<\/jats:sub>\n                    \u2009=\u200939.08\u2009\u00b1\u20093.4 \u00b5M). Mechanistically, treatment of HEP2 cells with compound\n                    <jats:bold>5b<\/jats:bold>\n                    significantly downregulated cyclin-dependent kinase (\n                    <jats:italic>CDK<\/jats:italic>\n                    )\n                    <jats:italic>4<\/jats:italic>\n                    and\n                    <jats:italic>CDK6<\/jats:italic>\n                    , key regulators of the cell cycle, while modulating ferroptosis-associated genes by suppressing transferrin (\n                    <jats:italic>TF<\/jats:italic>\n                    ) and upregulating heme oxygenase-1 (\n                    <jats:italic>HO-1<\/jats:italic>\n                    ). In contrast, compound\n                    <jats:bold>5c<\/jats:bold>\n                    induced apoptosis in MCF-7 cells by upregulating\n                    <jats:italic>TF<\/jats:italic>\n                    while downregulating autophagy-related 3 (\n                    <jats:italic>ATG3<\/jats:italic>\n                    ). Flow cytometric analysis indicated that both compounds promoted\n                    <jats:italic>ATG3<\/jats:italic>\n                    -independent autophagy and cell cycle arrest at G0\/G1 (in HEP2) and G2\/M (in MCF-7). Furthermore, these chalcone derivatives effectively induced P53-independent apoptosis, as evidenced by a significant increase in both early and late apoptotic phases. Molecular docking studies demonstrated a strong binding affinity of compound\n                    <jats:bold>5b<\/jats:bold>\n                    toward\n                    <jats:italic>CDK4<\/jats:italic>\n                    and\n                    <jats:italic>CDK6<\/jats:italic>\n                    , supporting its role in cell cycle inhibition. Overall, these findings suggest that the synthetic chalcone derivatives\n                    <jats:bold>5b<\/jats:bold>\n                    and\n                    <jats:bold>5c<\/jats:bold>\n                    possess promising anticancer activity, modulating key pathways involved in cell cycle regulation, apoptosis, ferroptosis, and autophagy, and emerge as strong candidates for further investigation in the development of new therapeutic agents.\n                  <\/jats:p>","DOI":"10.1007\/s00210-025-04940-z","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:38:15Z","timestamp":1768455495000},"page":"8867-8882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Synthesis and cytotoxicity of novel cyanochalcones: induction of cell cycle arrest, apoptosis, and autophagy in HEP2 and MCF-7 cells"],"prefix":"10.1007","volume":"399","author":[{"given":"Nada S.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr Ahmed","family":"WalyEldeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif Abdelaziz","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail A.","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba K. A.","family":"Elhakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"issue":"3","key":"4940_CR1","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1080\/10406638.2022.2039240","volume":"43","author":"RE Abdelwahab","year":"2023","unstructured":"Abdelwahab RE, Darweesh AF, Ragheb MA, Abdelhamid IA, Elwahy AHM (2023) Synthesis of new 2-(4-(1,4-dihydropyridin-4-yl)phenoxy)-n-arylacetamides and their heterocyclic-fused derivatives via Hantzsch-like reaction. Polycycl Aromat Compd 43(3):1974\u20131986. https:\/\/doi.org\/10.1080\/10406638.2022.2039240","journal-title":"Polycycl Aromat Compd"},{"key":"4940_CR2","doi-asserted-by":"crossref","unstructured":"Angela V, Vitto M, Bianchin S, Zolondick AA, Pellielo G, Rimessi A, \u2026 Patergnani S (2022) Molecular mechanisms of autophagy in cancer development, progression, and therapy. Biomedicines 10:1\u201330","DOI":"10.3390\/biomedicines10071596"},{"key":"4940_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/molecules16010523","volume":"16","author":"AM Asiri","year":"2011","unstructured":"Asiri AM, Khan SA (2011) Synthesis and anti-bacterial activities of a bis-chalcone derived from thiophene and its bis-cyclized products. Molecules 16:523\u2013531. https:\/\/doi.org\/10.3390\/molecules16010523","journal-title":"Molecules"},{"issue":"24","key":"4940_CR4","doi-asserted-by":"publisher","first-page":"8168","DOI":"10.1016\/j.bmc.2009.10.035","volume":"17","author":"BP Bandgar","year":"2009","unstructured":"Bandgar BP, Gawande SS, Bodade RG, Gawande NM, Khobragade CN (2009) Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents. Bioorg Med Chem 17(24):8168\u20138173. https:\/\/doi.org\/10.1016\/j.bmc.2009.10.035","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"4940_CR5","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.bmc.2004.01.037","volume":"12","author":"AA Bekhit","year":"2004","unstructured":"Bekhit AA, Abdel-Aziem T (2004) Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents. Bioorg Med Chem 12(8):1935\u20131945. https:\/\/doi.org\/10.1016\/j.bmc.2004.01.037","journal-title":"Bioorg Med Chem"},{"key":"4940_CR6","doi-asserted-by":"publisher","unstructured":"Bhutia SK, Mukhopadhyay S, Sinha N, Das DN, Panda PK, Patra SK, \u2026 Fisher PB (2013) Autophagy: Cancer\u2019s friend or foe? Advances in Cancer Research (1st ed., Vol. 118). Copyright \u00a9 2013 Elsevier Inc. All rights reserved. https:\/\/doi.org\/10.1016\/B978-0-12-407173-5.00003-0","DOI":"10.1016\/B978-0-12-407173-5.00003-0"},{"issue":"6","key":"4940_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers17060958","volume":"17","author":"I Buyukgolcigezli","year":"2025","unstructured":"Buyukgolcigezli I, Tenekeci AK, Sahin IH (2025) Opportunities and challenges in antibody\u2013drug conjugates for cancer therapy: a new era for cancer treatment. Cancers 17(6):1\u201320. https:\/\/doi.org\/10.3390\/cancers17060958","journal-title":"Cancers"},{"issue":"9","key":"4940_CR8","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/ncb2804","volume":"15","author":"TK Chang","year":"2013","unstructured":"Chang TK, Shravage BV, Hayes SD, Powers CM, Simin RT, Wade Harper J, Baehrecke EH (2013) Uba1 functions in Atg7- and Atg3-independent autophagy. Nat Cell Biol 15(9):1067\u20131078. https:\/\/doi.org\/10.1038\/ncb2804","journal-title":"Nat Cell Biol"},{"issue":"2","key":"4940_CR9","first-page":"341","volume":"8","author":"PS Dabhade","year":"2025","unstructured":"Dabhade PS, Dabhade MP, Dhawale SA, Rathod LS, More SA, Mokale SN (2025) Diaryl pyrazole-chalcone hybrids as novel ER-\u03b1 modulators: docking, synthesis and anti-breast cancer activity evaluation. Advanced Journal of Chemistry, Section A 8(2):341\u2013360","journal-title":"Advanced Journal of Chemistry, Section A"},{"issue":"1","key":"4940_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1416","volume":"10","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Stockwell BR (2014) The role of iron and reactive oxygen species in cell death. Nat Chem Biol 10(1):9\u201317. https:\/\/doi.org\/10.1038\/nchembio.1416","journal-title":"Nat Chem Biol"},{"key":"4940_CR11","doi-asserted-by":"publisher","unstructured":"Elgamal AM, Salem ME, Hamed AA, Abdelhamid IA, Abdallah TA, Ali HA, \u2026, Ragheb MA (2025) Synthesis, characterization, and applications of chitosan-isatin Schiff base tethered N-(4-methoxyphenyl)acetamide: adsorption, docking, antioxidant, and antibacterial properties. Carbohydr Polym 369(1):124258. https:\/\/doi.org\/10.1016\/J.CARBPOL.2025.124258","DOI":"10.1016\/J.CARBPOL.2025.124258"},{"issue":"1","key":"4940_CR12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1186\/s12885-023-11649-w","volume":"23","author":"B Emad","year":"2023","unstructured":"Emad B, WalyEldeen AA, Hassan H, Sharaky M, Abdelhamid IA, Ibrahim SA, Mohamed HR (2023) Yttrium oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells. BMC Cancer 23(1):1151. https:\/\/doi.org\/10.1186\/s12885-023-11649-w","journal-title":"BMC Cancer"},{"issue":"5","key":"4940_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.21608\/ejchem.2024.285279.9803","volume":"68","author":"HM Fahmy","year":"2025","unstructured":"Fahmy HM, Hamed MM, Monem AS (2025) Evaluation of the cytotoxicity of mesoporous silica nanoparticles loaded with gallic acid on laryngeal cancer (HEP-2) cell lines. Egypt J Chem 68(5):167\u2013178. https:\/\/doi.org\/10.21608\/ejchem.2024.285279.9803","journal-title":"Egypt J Chem"},{"issue":"3","key":"4940_CR14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/15548627.2015.1017181","volume":"11","author":"S Guo","year":"2015","unstructured":"Guo S, Liang Y, Murphy SF, Huang A, Shen H, Kelly DF, Sobrado Pablo, Sheng Z (2015) A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications. Autophagy 11(3):560\u2013572","journal-title":"Autophagy"},{"issue":"1","key":"4940_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1749-6632.2009.04904.x","volume":"1171","author":"MR Heidari","year":"2009","unstructured":"Heidari MR, Foroumadi A, Amirabadi A, Samzadeh-Kermani A, Azimzadeh BS, Eskandarizadeh A (2009) Evaluation of anti-inflammatory and analgesic activity of a novel rigid 3, 4-dihydroxy chalcone in mice. Ann N Y Acad Sci 1171(1):399\u2013406. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04904.x","journal-title":"Ann N Y Acad Sci"},{"key":"4940_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2019.113317","volume":"255","author":"W Huang","year":"2019","unstructured":"Huang W, Cao Z, Zhang J, Ji Q, Li Y (2019) Aflatoxin B1 promotes autophagy associated with oxidative stress-related PI3K\/AKT\/mTOR signaling pathway in mice testis. Environ Pollut 255:113317. https:\/\/doi.org\/10.1016\/j.envpol.2019.113317","journal-title":"Environ Pollut"},{"key":"4940_CR17","doi-asserted-by":"publisher","first-page":"10091","DOI":"10.1007\/s00210-024-03255-9","volume":"397","author":"NS Ibrahim","year":"2024","unstructured":"Ibrahim NS, Sayed HA, Sharaky M, Diab HM, Elwahy AHM, Abdelhamid IA (2024) Synthesis, cytotoxicity, anti-inflammatory, anti-metastatic and anti-oxidant activities of novel chalcones incorporating 2-phenoxy-N-arylacetamide and thiophene moieties: induction of apoptosis in MCF7 and HEP2 cells. Naunyn-Schmiedebergs Arch Pharmacol 397:10091\u201310107. https:\/\/doi.org\/10.1007\/s00210-024-03255-9","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"4940_CR18","doi-asserted-by":"publisher","unstructured":"Ibrahim NS, Elghany RAA, Sharaky M et al (2025) Synthesis, cytotoxicity, antiproliferative, antioxidant, anti-inflammatory, and antimetastatic activities of novel 2-arylidene-indane-1,3-dione scaffolds incorporating 2-phenoxy-N-arylacetamide moiety: induction of apoptosis in Hela cells. J Mol Struct 1328:141424. https:\/\/doi.org\/10.1016\/j.molstruc.2025.141424","DOI":"10.1016\/j.molstruc.2025.141424"},{"issue":"1","key":"4940_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.9734\/ajopacs\/2025\/v13i1241","volume":"13","author":"SM Isyaka","year":"2025","unstructured":"Isyaka SM, Morgan OC, Umar A, Abdullahi AM, Adam AS (2025) Anticancer bioactive compounds from Nigerian medicinal plants: a review. Asian J Phys Chem Sci 13(1):44\u201363","journal-title":"Asian J Phys Chem Sci"},{"key":"4940_CR20","doi-asserted-by":"publisher","unstructured":"Kumar D, Kumar NM, Tantak MP, Ogura M, Kusaka E (2014) Synthesis and identification of \u03b1 -cyano bis (indolyl) chalcones as novel anticancer agents. Bioorg Med Chem Lett 22(15):5170\u20135174. https:\/\/doi.org\/10.1016\/j.bmcl.2014.09.085","DOI":"10.1016\/j.bmcl.2014.09.085"},{"issue":"1","key":"4940_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00726-023-03364-4","volume":"56","author":"LB Kwantwi","year":"2024","unstructured":"Kwantwi LB (2024) The dual role of autophagy in the regulation of cancer treatment. Amino Acids 56(1):1\u20137. https:\/\/doi.org\/10.1007\/s00726-023-03364-4","journal-title":"Amino Acids"},{"issue":"1\u20132","key":"4940_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine B, Kroemer G (2019) Biological functions of autophagy genes: a disease perspective. Cell 176(1\u20132):11\u201342. https:\/\/doi.org\/10.1016\/j.cell.2018.09.048","journal-title":"Cell"},{"issue":"26","key":"4940_CR23","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1021\/jm00026a010","volume":"38","author":"R Li","year":"1995","unstructured":"Li R, Kenyon GL, Cohen FE, Chen X, Gong B, Dominguez JN, Davidson Eugene, Kurzban Gary, Miller Robert E., Nuzum Edwin O., Rosenthal Philip J., McKerrow JH (1995) In vitro antimalarial activity of chalcones and their derivatives. J Med Chem 38(26):5031\u20135037. https:\/\/doi.org\/10.1021\/jm00026a010","journal-title":"J Med Chem"},{"issue":"1","key":"4940_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/ddr.1163","volume":"53","author":"C-N Lin","year":"2001","unstructured":"Lin C-N, Hsieh H-K, Ko H-H, Hsu M-F, Lin H-C, Chang Y-L, Lin Chun\u2010Nan, Hsieh Hsin\u2010Kaw, Ko Horng\u2010Huey, Hsu Mei\u2010Feng, Lin Hsien\u2010Cheng, Chang Ya\u2010Ling, Chung Mei\u2010Ing, Kang Jaw\u2010Jou, Wang Jih\u2010Pyang, Teng Che\u2010Ming, Teng C-M (2001) Chalcones as potent antiplatelet agents and calcium channel blockers. Drug Dev Res 53(1):9\u201314. https:\/\/doi.org\/10.1002\/ddr.1163","journal-title":"Drug Dev Res"},{"issue":"4","key":"4940_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method. Methods 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"1","key":"4940_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/nyas.13008","volume":"1368","author":"DH Manz","year":"2016","unstructured":"Manz DH, Blanchette NL, Paul BT, Torti FM, Torti SV (2016) Iron and cancer: recent insights. Ann N Y Acad Sci 1368(1):149\u2013161. https:\/\/doi.org\/10.1111\/nyas.13008","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"4940_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1534\/genetics.109.102327","volume":"182","author":"LM McNamee","year":"2009","unstructured":"McNamee LM, Brodsky MH (2009) P53-independent apoptosis limits DNA damage-induced aneuploidy. Genetics 182(2):423\u2013435. https:\/\/doi.org\/10.1534\/genetics.109.102327","journal-title":"Genetics"},{"key":"4940_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030503","author":"R Michalkova","year":"2022","unstructured":"Michalkova R, Kello M, Kudlickova Z, Gazdova M, Mirossay L, Mojzisova G, Mojzis J (2022) Programmed cell death alterations mediated by synthetic indole chalcone resulted in cell cycle arrest, DNA damage, apoptosis and signaling pathway modulations in breast cancer model. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14030503","journal-title":"Pharmaceutics"},{"issue":"5","key":"4940_CR29","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s12010-012-9848-8","volume":"168","author":"MF Mohamed","year":"2012","unstructured":"Mohamed MF, Mohamed MS, Shouman Sa, Fathi MM, Abdelhamid IA (2012) Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents. Appl Biochem Biotechnol 168(5):1153\u20131162. https:\/\/doi.org\/10.1007\/s12010-012-9848-8","journal-title":"Appl Biochem Biotechnol"},{"issue":"9","key":"4940_CR30","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.2174\/187152061409141010114547","volume":"14","author":"MF Mohamed","year":"2014","unstructured":"Mohamed MF, Mohamed MS, Fathi MM, Shouman SA, Abdelhamid IA (2014) Chalcones incorporated pyrazole ring inhibit proliferation , cell cycle progression , angiogenesis and induce apoptosis of MCF7 cell line. Anticancer Agents Med Chem 14(9):1282\u20131292","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"4940_CR31","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ejmech.2017.11.045","volume":"143","author":"MF Mohamed","year":"2018","unstructured":"Mohamed MF, Hassaneen HM, Abdelhamid IA (2018) Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones. Eur J Med Chem 143(1):532\u2013541. https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.045","journal-title":"Eur J Med Chem"},{"issue":"7","key":"4940_CR32","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1016\/j.arabjc.2020.04.032","volume":"13","author":"MF Mohamed","year":"2020","unstructured":"Mohamed MF, Elhakim HKA, Saddiq AA, Abdelhamid IA (2020) A novel inhibitor, 2-cyano-3-(1-phenyl-3-(thiophen-2-yl)-pyrazol-4-yl)acrylamide linked to sulphamethoxazole, blocks anti-apoptotic proteins via molecular docking and strongly induced apoptosis of HCT116 cell line by different molecular tools. Arab J Chem 13(7):5978\u20135995. https:\/\/doi.org\/10.1016\/j.arabjc.2020.04.032","journal-title":"Arab J Chem"},{"issue":"1","key":"4940_CR33","doi-asserted-by":"publisher","first-page":"22486","DOI":"10.1038\/s41598-023-48494-7","volume":"13","author":"MF Mohamed","year":"2023","unstructured":"Mohamed MF, Ibrahim NS, Saddiq AA, Abdelhamid IA (2023) Novel 3-(pyrazol-4-yl)-2-(1H-indole-3-carbonyl)acrylonitrile derivatives induce intrinsic and extrinsic apoptotic death mediated P53 in HCT116 colon carcinoma. Sci Rep 13(1):22486. https:\/\/doi.org\/10.1038\/s41598-023-48494-7","journal-title":"Sci Rep"},{"key":"4940_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJBIOMAC.2025.142048","volume":"308","author":"MF Mohamed","year":"2025","unstructured":"Mohamed MF, Hamed AA, Kashmiry AA, Saddiq AA, Abdelhamid IA, Elgamal AM (2025) A practical and environmentally sustainable approach to dye removal: synthesis and characterization of a highly efficient crosslinked chitosan-Schiff base adsorbent for Eriochrome Black T removal. Int J Biol Macromol 308:142048. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2025.142048","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"4940_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.resp.2012.06.027","volume":"184","author":"JA Neubauer","year":"2012","unstructured":"Neubauer JA, Sunderram J (2012) Heme oxygenase-1 and chronic hypoxia. Respir Physiol Neurobiol 184(2):178\u2013185. https:\/\/doi.org\/10.1016\/j.resp.2012.06.027","journal-title":"Respir Physiol Neurobiol"},{"key":"4940_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.24820\/ark.5550190.p011.690","volume":"10","author":"RS Omar","year":"2021","unstructured":"Omar RS, Ragheb MA, Elwahy AHM, Abdelhamid IA (2021) Facile one-pot, three-component synthesis of novel fused 4H-pyrans incorporating 2-phenoxy-N-phenylacetamide core as novel hybrid molecules via Michael addition reaction. ARKIVOC 10:183\u2013198. https:\/\/doi.org\/10.24820\/ark.5550190.p011.690","journal-title":"ARKIVOC"},{"issue":"P4","key":"4940_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.144034","volume":"311","author":"MA Ragheb","year":"2025","unstructured":"Ragheb MA, Ragab MS, Mahdy FY, Elsebaie MS, Saber AM, AbdElmalak YO, Salah-Eldin DS (2025) Folic acid-modified chitosan nanoparticles for targeted delivery of a binuclear Co(II) complex in cancer therapy. Int J Biol Macromol 311(P4):144034. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144034","journal-title":"Int J Biol Macromol"},{"key":"4940_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJBIOMAC.2025.148298","volume":"331","author":"MA Ragheb","year":"2025","unstructured":"Ragheb MA, Salem ME, Hamed AA, Abdelhamid IA, Ali HA, Abdel-Megid M, Elgamal AM (2025) New isatin-chitosan Schiff base hybrids: tri-functional bioactives for antimicrobial, anticancer, and antioxidant therapies supported by in silico docking and ADMET studies. Int J Biol Macromol 331:148298. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2025.148298","journal-title":"Int J Biol Macromol"},{"issue":"P4","key":"4940_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.144100","volume":"311","author":"HM Salem","year":"2025","unstructured":"Salem HM, Orabi AH, Abdelhamid IA, Saad GR, Ismaiel DA, Hamed AA (2025) Synthesis and characterization of chitosan bearing indole linked N-arylacetamide moiety for effective removal of uranyl ions from waste solution. Int J Biol Macromol 311(P4):144100. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144100","journal-title":"Int J Biol Macromol"},{"key":"4940_CR40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ejmech.2013.01.018","volume":"62","author":"S Shenvi","year":"2013","unstructured":"Shenvi S, Kumar K, Hatti KS, Rijesh K, Diwakar L, Reddy GC (2013) Synthesis, anticancer and antioxidant activities of 2,4,5-trimethoxy chalcones and analogues from asaronaldehyde: structure\u2013activity relationship. Eur J Med Chem 62:435\u2013442. https:\/\/doi.org\/10.1016\/j.ejmech.2013.01.018","journal-title":"Eur J Med Chem"},{"issue":"5","key":"4940_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms26052238","volume":"26","author":"V Silva","year":"2025","unstructured":"Silva V, Mu\u00f1oz E, Ferreira C, Russo A, Villena J, Montenegro I, Madrid A (2025) In vitro and in silico cytotoxic activity of isocordoin from adesmia balsamica against cancer cells. Int J Mol Sci 26(5):1\u201313. https:\/\/doi.org\/10.3390\/ijms26052238","journal-title":"Int J Mol Sci"},{"issue":"34","key":"4940_CR42","doi-asserted-by":"publisher","first-page":"10113","DOI":"10.1002\/slct.201901415","volume":"4","author":"FM Sroor","year":"2019","unstructured":"Sroor FM, Abdelmoniem AM, Abdelhamid IA (2019) Facile synthesis, structural activity relationship, molecular modeling and in vitro biological evaluation of new urea derivatives with incorporated isoxazole and thiazole moieties as anticancer agents. ChemSelect 4(34):10113\u201310121. https:\/\/doi.org\/10.1002\/slct.201901415","journal-title":"ChemSelect"},{"issue":"10","key":"4940_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202000069","volume":"353","author":"FM Sroor","year":"2020","unstructured":"Sroor FM, Aboelenin MM, Mahrous KF, Mahmoud K, Elwahy AHM, Abdelhamid IA (2020) Novel 2-cyanoacrylamido-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as potent anticancer agents. Arch Pharm (Weinheim) 353(10):e2000069. https:\/\/doi.org\/10.1002\/ardp.202000069","journal-title":"Arch Pharm (Weinheim)"},{"issue":"1","key":"4940_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-023-01014-0","volume":"17","author":"FM Sroor","year":"2023","unstructured":"Sroor FM, Tohamy WM, Zoheir K, Abdelazeem NM, Mahrous KF, Ibrahim NS (2023) Design, synthesis, in vitro anticancer, molecular docking and SAR studies of new series of pyrrolo [2, 3-d] pyrimidine derivatives. BMC Chem 17(1):1\u201328","journal-title":"BMC Chem"},{"key":"4940_CR45","doi-asserted-by":"publisher","unstructured":"WalyEldeen AA, El-Shorbagy HM, Hassaneen HM et al (2022) [1,2,4] Triazolo [3,4-a]isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid carcinoma-bearing mice. Naunyn Schmiedebergs Arch Pharmacol 395:1225\u20131238. https:\/\/doi.org\/10.1007\/s00210-022-02269-5","DOI":"10.1007\/s00210-022-02269-5"},{"key":"4940_CR46","doi-asserted-by":"publisher","unstructured":"WalyEldeen AA, Sabet S, El-Shorbagy HM et al (2023) Chalcones: promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer. Chem Biol Interact 369:110297. https:\/\/doi.org\/10.1016\/j.cbi.2022.110297","DOI":"10.1016\/j.cbi.2022.110297"},{"key":"4940_CR47","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.7150\/jca.97775","volume":"15","author":"M Wang","year":"2024","unstructured":"Wang M, Liu M, Yang C, Hu Y, Liao X, Liu Q (2024) Autophagy modulation in therapeutic strategy of breast cancer drug resistance. J Cancer 15:5462\u20135476. https:\/\/doi.org\/10.7150\/jca.97775","journal-title":"J Cancer"},{"key":"4940_CR48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/cas.16404","volume":"116","author":"X Zhu","year":"2024","unstructured":"Zhu X, Zhong M, Wang Q, Zhang MJ (2024) LncRNA MIR600HG inhibits laryngeal cancer development by mediating the miR-424-5p\/BTG2 axis. Cancer Sci 116:544\u2013558. https:\/\/doi.org\/10.1111\/cas.16404","journal-title":"Cancer Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04940-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04940-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04940-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:38:24Z","timestamp":1776393504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04940-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4940"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04940-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}